Technical report

Hydroxyapatite-coated cardiovascular stents

EuroIntervention 2006;2:113-115 - DOI10.4244/EIJV2I1A18.

A Rajtar
A. Rajtar*, G. L. Kaluza, Q. Yang, D. Hakimi, D. Liu, M. Tsui, M. Lien, D. Smith, F. J. Clubb, Jr. and T. Troczynski
MIV Therapeutics, Vancouver, BC, Canada

Extensive clinical practice supported with evidence gathered during numerous animal studies has shown that in addition to its excellent biocompatibility, hydroxyapatite (HAp, a crystalline derivative of calcium p

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
The Recover® LP2.5 catheter-mounted left ventricular assist device

Latest news